Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Humana (NY:HUM)

286.39 +5.05 (+1.79%)
Official Closing Price Updated: 7:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Humana

< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
UnitedHealth Stock Gets Fresh Fuel From Dividend Nod — Now Retail Traders Are Whispering About Warren Buffett Taking Stake
Speculation over a potential Berkshire Hathaway stake, alongside big moves from notable institutional investors, has added to the momentum in UnitedHealth shares. 
Via Stocktwits
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy Lawsuit
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Is the Market Bullish or Bearish on Humana?
 
Via Benzinga
Humana Stock Gains On Upbeat Earnings And Raised Guidance, Drawing Retail Praise And UnitedHealth Contrasts
Via Stocktwits
Earnings Scheduled For July 30, 2025
 
Via Benzinga
Amphastar Pharmaceuticals, QuidelOrtho, Integra LifeSciences, Select Medical, and Regeneron Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Lawsuit
HUM Q2 Deep Dive: Pharmacy Strength, Medicaid Expansion, and Guidance Lift
Health insurance company Humana (NYSE:HUM) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 9.6% year on year to $32.39 billion. The company’s full-year revenue guidance... 
Via StockStory
The Top 5 Analyst Questions From Humana’s Q2 Earnings Call
Humana delivered a second quarter that outpaced Wall Street’s expectations, with management highlighting CenterWell Pharmacy’s strong performance and stable medical cost trends as key drivers. CEO... 
Via StockStory
Topics Earnings
Why LifeStance Health Group (LFST) Stock Is Up Today
Shares of behavioral health company LifeStance Health (NASDAQ:LFST) jumped 11% in the afternoon session after the company reported mixed second-quarter 2025 results, delivering an earnings beat and a... 
Via StockStory
Topics Earnings Initial Public Offering Lawsuit
Why Astrana Health (ASTH) Stock Is Trading Up Today
Shares of healthcare services company Astrana Health jumped 34.2% in the morning session after the company reported better-than-expected second-quarter sales and significantly raised its full-year... 
Via StockStory
Topics Lawsuit
Why Lantheus (LNTH) Stock Is Falling Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 29.8% in the afternoon session after the company reported disappointing second-quarter financial results and slashed its... 
Via StockStory
Topics Lawsuit
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today
Via Stocktwits
HUMANA (HUM) ALERT: Bragar Eagel & Squire, P.C. is Investigating Humana Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CVS Health CFO Says Company Maintaining Prudent View On Medical Cost Trends Through Remainder Of Year
The firm now expects full-year adjusted earnings per share of $6.30 to $6.40, up from its previous guidance of $6.00 to $6.20. 
Via Stocktwits
Topics Artificial Intelligence Earnings Workforce
Humana (HUM) Q2 Revenue Rises 10%
Via The Motley Fool
Topics Earnings
Stay informed with the top movers within the S&P500 index on Wednesday.
Let's delve into the developments on the US markets one hour before the close of the markets on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
These S&P500 stocks have an unusual volume in today's session
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. 
Via Chartmill
Wednesday's session: top gainers and losers in the S&P500 index
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Why Humana (HUM) Stock Is Trading Up Today
Shares of health insurance company Humana (NYSE:HUM) jumped 4.9% in the morning session after the company reported better-than-expected second-quarter results and raised its full-year financial... 
Via StockStory
Topics Lawsuit
Why Supernus Pharmaceuticals (SUPN) Stock Is Up Today
Shares of specialty pharmaceutical company Supernus Pharmaceuticals (NASDAQ:SUPN) jumped 3.1% in the morning session after Cantor Fitzgerald upgraded the stock to Overweight from Neutral and raised its... 
Via StockStory
Topics Lawsuit
Humana Boosts 2025 Profit Guidance, Plans $100 Million In Strategic Investments
Humana beat Q2 EPS and revenue estimates and raised its 2025 outlook, driven by strong PDP growth and higher CenterWell patient volumes. 
Via Benzinga
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate. 
Via Stocktwits
Topics Artificial Intelligence World Trade
These S&P500 stocks that are showing activity before the opening bell on Wednesday.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements. 
Via Chartmill
Humana’s (NYSE:HUM) Q2 Sales Beat Estimates, Full-Year Outlook Slightly Exceeds Expectations
Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2025, with sales up 9.6% year on year to $32.39 billion. The company’s full-year revenue guidance of $128... 
Via StockStory
Topics Earnings
Humana Reports Second Quarter 2025 Financial Results; Raises Full Year 2025 Adjusted EPS and Revenue Guidance
From Humana Inc.
Via Business Wire
US Stock Futures Hold Up As Traders Await Meta, Microsoft Earnings — Economists Discount Dovish Fed Ahead Of Rate Decision
Investors may also keep an eye on any developments on the trade news front as President Donald Trump’s Aug. 1 tariff deadline draws closer. 
Via Stocktwits
Topics ETFs Economy Government
Why NeoGenomics (NEO) Shares Are Falling Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 20.2% in the morning session after the company reported second-quarter results that included a significant cut to its... 
Via StockStory
Topics Lawsuit
Why Repligen (RGEN) Stock Is Up Today
Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 7.8% in the morning session after the company reported strong second-quarter 2025 financial results and raised its... 
Via StockStory
Topics Artificial Intelligence Lawsuit
< Previous 1 2 3 4 5 6 7 8 9
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.